Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | TET2 | Q6N021 | 4/20 | 0.33 |
| ▸ | TET3 | O43151 | 1/20 | 0.33 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.32 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.32 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.32 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.32 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.30 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.30 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1824152 | 1.00 | HIF1A (0.41) | HIF1AALOX15HSD17B10TBXAS1TSHR | |
| SCHEMBL2046603 | 0.93 | MAPT (0.40) | HIF1AALOX15HSD17B10TBXAS1TSHR | |
| SCHEMBL1832017 | 0.93 | MAPT (0.40) | HIF1AALOX15HSD17B10TBXAS1TSHR | |
| SCHEMBL10337658 | 0.91 | MAPT (0.43) | HIF1AALOX15HSD17B10TBXAS1TSHR | |
| SCHEMBL16661276 | 0.91 | MAPT (0.43) | HIF1AALOX15HSD17B10TBXAS1TSHR | |
| SCHEMBL4953960 | 0.91 | MAPT (0.43) | HIF1AALOX15HSD17B10TBXAS1TSHR | |
| SCHEMBL1821741 | 0.85 | — | — | |
| SCHEMBL2119324 | 0.81 | MAPT (0.52) | ALOX15HSD17B10TBXAS1TSHRTET2 | |
| SCHEMBL720674 | 0.79 | ALOX15 (0.35) | ALOX15HSD17B10TBXAS1TET2TET3 | |
| SCHEMBL10792586 | 0.79 | HIF1A (0.39) | HIF1ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110144267-A1 | FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD | EVONIK ROEHM GMBH (DE) | 2011-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144267-A1 | FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD | DNMT1, TET1, MGMT | HIF1A 161/4885ALOX15 3498/4885HSD17B10 1425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.